Repositório PUCRS
metadata only
Efeito protetor do resveratrol na hepatotoxicidade induzida por fármacos anti-tuberculose Isoniazida e Rifampicina em camundongos
Background/Aims: Isoniazid (INH) and Rifampicin (RIF) are the first-line drugs used for tuberculosis (TB) treatment. Hepatotoxicity induced by anti-TB drugs leads to substantial morbidity, diminishing treatment effectiveness. Herein, we have investigated the effects of resveratrol (RSV) in the hepat
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genotype-guided isoniazid dosing harmonizes drug exposure in 3HP tuberculosis preventive therapy#1136721
- Determining the Ability of Resveratrol to Inhibit HCBR Activity#493125
- Evaluation of Resveratrol and Its Loaded Nanoparticles on Acanthamoeba#1125809
- Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trial.#150284
- The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients#837306
Record · ID 946250
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive